New treatment for rare blood cancer The U.S. Food and Drug Administration (FDA) has approved Tibsovo (ivosidenib) for the treatment of adult patients with relapsed or refractory myelodysplastic syndromes (MDS) who have an isocitrate dehydrogenase-1 (IDH1) mutation. MDS is a rare form of blood cancer caused by mutations in bone marrow cells, leading to a […]
Read MoreAuthors: Zachariah P.G. Olufs, B.S. et al Anesthesiology December 2023. Background Carriers of mutations in the mitochondrial electron transport chain (mETC) are at increased risk of anesthetic-induced neurotoxicity. To investigate the neurotoxicity mechanism and to test preconditioning as a protective strategy, we used a Drosophila melanogaster model of Leigh syndrome. Model flies carried a mutation in ND23 (ND2360114) that encodes […]
Read MoreAUTHORS: Fritz, Bradley A. MD, MSCI et al Anesthesia & Analgesia June 2023. BACKGROUND: Machine learning models can help anesthesiology clinicians assess patients and make clinical and operational decisions, but well-designed human-computer interfaces are necessary for machine learning model predictions to result in clinician actions that help patients. Therefore, the goal of this study […]
Read MoreAuthors: Dinesh Ramaiah MBBS et al O THE EDITOR We appreciate the reprinting in the APSF Newsletter of the article from Anesthesia & Analgesia, (June 2022 • Volume 134 • Number 6, pages 1192–1200), entitled “Pro-Con Debate: Monitored Anesthesia Care Versus General Endotracheal Anesthesia for Endoscopic Retrograde Cholangiopancreatography” by Janik et al., and we hope that in reprinting […]
Read MoreAuthors: Aalok V. Agarwala, MD, MBA et al The transition of responsibility and accountability for patient care from one clinical team to another is a routine part of modern health care delivery. Whether between physical locations (e.g., from the emergency department to an inpatient floor), or between teams in a static location (e.g., from a […]
Read MoreAuthor: Toby N. Weingarten, MD Anesthesia Patient Safety Foundation Volume 38, No. 2 • June 2023 More than a decade ago the APSF established a clear edict: “No patient should be harmed by opioid-induced respiratory depression in the postoperative period.”1 Research studies established a strong association between obstructive sleep apnea (OSA) and adverse postoperative opioid-related outcomes. In […]
Read MoreAUTHORS: Das, Vaskar PhD et al Anesthesia & Analgesia June 2023. BACKGROUND: The ketamine metabolite (2R,6R)-hydroxynorketamine ([2R,6R]-HNK) has analgesic efficacy in murine models of acute, neuropathic, and chronic pain. The purpose of this study was to evaluate the α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) dependence of (2R,6R)-HNK analgesia and protein changes in the hippocampus in murine pain models administered […]
Read MoreAUTHORS: Coëffic, Adrien MD et al Anesthesia & Analgesia June 2023. BACKGROUND: Changes in arterial partial pressure of carbon dioxide (Paco2) may alter cerebral perfusion in critically ill patients with acute brain injury. Consequently, international guidelines recommend normocapnia in mechanically ventilated patients with acute brain injury. The measurement of end-tidal capnography (Etco2) allows its approximation. […]
Read MoreAUTHORS: Varney, Bianca MIPH et al Anesthesia & Analgesia June 2023. BACKGROUND: Opioid analgesics are used for acute postpartum pain relief but carry risks, including persistent long-term opioid use. Our primary objective was to estimate the prevalence of persistent use following hospital discharge after childbirth. METHODS: We conducted a population-based cohort study of women discharged […]
Read MoreAuthors: Marijn P. Mulder, M.Sc. et al Anesthesiology June 2023, Vol. 138, 657–658. To the Editor: The Hypotension Prediction Index is a validated machine learning algorithm based on numerous characteristics of the arterial waveform and aimed at predicting hypotension up to 15 min in advance. The recent special article by Enevoldsen and Vistisen focused on the data […]
Read More